Best Benzodiazepine Alternatives (2026)

Benzodiazepines — Xanax (alprazolam), Klonopin (clonazepam), and Ativan (lorazepam) are the most prescribed — work within minutes and are genuinely effective for acute anxiety. The tradeoff is real: physical dependence can build within weeks of regular use, tolerance can develop, and long-term use is linked to cognitive and fall-risk concerns in some populations. That's why many prescribers and patients look for alternatives for ongoing (not just acute, situational) anxiety. This guide covers six real, evidence-backed alternatives, ranked by evidence, dependence risk, and access.

Why people look for benzodiazepine alternatives

The most common reasons are dependence risk, tolerance, and a preference for a daily-use medication that doesn't carry a controlled- substance stigma or withdrawal risk. Specific drivers include:

• Physical dependence — can develop within weeks of regular (not just occasional) use, independent of misuse.
• Tolerance — needing a higher dose over time to get the same anti-anxiety effect.
• Withdrawal risk — benzodiazepine withdrawal, unlike most antidepressant discontinuation, can cause seizures if stopped abruptly after regular use.
• Cognitive and fall-risk concerns — particularly relevant for older adults on long-term benzodiazepines.
• Wanting a maintenance option — benzodiazepines are generally recommended short-term; most guidelines favor SSRIs/SNRIs or therapy for ongoing anxiety disorders.

1. SSRIs / SNRIs — Best overall daily alternative

SSRIs (sertraline, escitalopram, paroxetine) and SNRIs (venlafaxine, duloxetine) are first-line, guideline-recommended treatments for generalized anxiety disorder, panic disorder, and social anxiety disorder. Several are specifically FDA-approved for these anxiety diagnoses — this is a real regulatory difference from benzodiazepines, which are typically approved only for short-term anxiety relief.

The tradeoff is speed: SSRIs/SNRIs take 2–6 weeks to build a full effect, so they don't help an acute panic attack the way a benzodiazepine does. Some people also see a temporary increase in anxiety in the first one to two weeks. Neither drug class carries physical dependence risk in the benzodiazepine sense, though stopping either abruptly can cause discontinuation symptoms and should be tapered. See our SSRI alternatives guide if the issue is SSRI side effects specifically rather than benzodiazepines.

Best for: Ongoing generalized anxiety, panic disorder, or social anxiety where daily maintenance (not acute rescue) is the goal.

2. Buspirone (Buspar) — Best non-addictive daily option

Buspirone is a serotonin 5-HT_1A partial agonist, FDA-approved specifically for generalized anxiety disorder. Unlike benzodiazepines, it carries no meaningful dependence or withdrawal risk and is not a controlled substance. It is often the closest like-for-like daily replacement people look for after a benzodiazepine.

The catch is timing: buspirone takes about 2–4 weeks to reach full effect and does nothing for an acute panic episode. It also tends to work best for generalized, free-floating anxiety rather than panic disorder specifically. Side effects are generally mild — dizziness, nausea, headache — with no sedation and no next-day cognitive fog.

Best for: People who want a genuinely non-addictive daily option and can tolerate a multi-week onset; generalized anxiety more than panic disorder.

3. Cognitive behavioral therapy (CBT) — Best non-drug option

CBT, particularly exposure-based CBT for panic disorder and social anxiety, has some of the strongest long-term evidence of any anxiety treatment — drug or non-drug. It treats the underlying anxiety pattern rather than suppressing symptoms, which is part of why gains from CBT tend to hold up after treatment ends, unlike medication effects that can fade when the drug is stopped.

The tradeoff is effort and time: a full course is typically 12–20 weekly sessions, and it requires active participation (practicing exposure exercises between sessions) rather than passively taking a pill. Many people combine CBT with a medication like an SSRI for faster initial relief while therapy skills build.

Best for: People who want durable, drug-free anxiety skills; panic disorder and social anxiety specifically respond well to exposure-based CBT.

4. Hydroxyzine (Vistaril) — Best non-addictive fast-acting option

Hydroxyzine is an antihistamine, FDA-approved for anxiety, that works within about an hour — much closer to benzodiazepine speed than SSRIs, buspirone, or CBT. It is not a controlled substance and carries no known dependence or withdrawal risk, which makes it one of the only genuinely fast-acting, non-addictive options on this list.

The main drawback is sedation — it's an antihistamine, so drowsiness is the most common side effect, and it's not intended for long-term daily maintenance the way an SSRI is. Some prescribers use it as an as-needed bridge for acute anxiety spikes while a slower-acting medication like an SSRI takes effect.

Best for: Occasional acute anxiety relief without dependence risk; bridging the gap while an SSRI/SNRI or buspirone takes effect.

5. Beta-blockers (propranolol) — Best for situational/performance anxiety

Propranolol blocks the physical symptoms of anxiety — racing heart, shaking hands, sweating — by blunting the adrenaline response. It is used off-label (not FDA-approved specifically for anxiety disorders) for situational anxiety: public speaking, performance anxiety, or a specific known stressor, taken as needed roughly 30–60 minutes beforehand.

It does not address the psychological/cognitive side of anxiety — racing thoughts, dread, worry — the way SSRIs, buspirone, or CBT do, and it isn't intended for generalized, all-day anxiety. It carries no dependence risk. People with asthma, certain heart conditions, or low blood pressure should not take it without medical clearance.

Best for: Situational or performance anxiety with a known trigger and predictable timing; not a fit for generalized or unpredictable anxiety.

6. Ketamine — Off-label, early evidence, not FDA-approved for anxiety

Ketamine and Spravato (esketamine) are FDA-approved only for treatment-resistant depression — not for any anxiety diagnosis. Some clinics use ketamine off-label for anxiety, often in patients who also have depression, based on early studies suggesting a possible benefit. This is meaningfully less established than ketamine's depression evidence, and it should be treated as investigational rather than a proven anxiety treatment.

Where it may be considered is treatment-resistant anxiety with a comorbid depression diagnosis, discussed explicitly with a psychiatrist as an off-label option — not as a first, second, or even third-line anxiety treatment. Read our full ketamine guide for access, cost, and safety details.

Best for: Comorbid treatment-resistant depression and anxiety, only as an off-label option discussed directly with a psychiatrist — not a first-line anxiety treatment.

7. Psilocybin & LSD (MM120) — Trial-stage, not legally available for anxiety

Two classic psychedelics have real but early trial data for anxiety specifically, distinct from their depression evidence:

Psilocybin: Single-dose psilocybin reduced anxiety and depression in patients with life-threatening cancer diagnoses in controlled trials at Johns Hopkins and NYU, with effects that in some patients lasted months after one session.¹ This is specific to cancer-related existential anxiety, not generalized anxiety disorder, and psilocybin has no FDA approval for any anxiety indication. Where it's legally accessible at all (Oregon and Colorado licensed service centers), it's accessed under those states' regulated programs, not as an anxiety prescription.

LSD (MindMed's MM120): This is the closest thing to a dedicated anxiety-specific psychedelic drug development program. MM120 received FDA Breakthrough Therapy Designation for generalized anxiety disorder after a Phase 2b trial showed a large, statistically significant reduction in anxiety symptoms, and it entered Phase 3 trials.² As of 2026 it is still an investigational drug — not FDA-approved and not legally available outside a clinical trial. See our LSD vs psilocybin guide for more on the trial timeline.

For either drug, the only legal way to access it for anxiety today is a clinical trial. Our find a clinical trial tool can help you check current enrollment.

Best for: People who want to track emerging, non-daily-medication anxiety treatments or are eligible for a clinical trial — not a currently accessible option outside research settings.

Benzodiazepine alternatives: side-by-side comparison

Which benzodiazepine alternative is right for you?

Best overall for ongoing anxiety: SSRIs or SNRIs — guideline-recommended, several FDA-approved specifically for anxiety disorders, and no dependence risk.

Best non-addictive daily match: Buspirone — closest to a like-for-like daily replacement, though it needs a few weeks to build an effect.

Best non-drug option: CBT — the most durable results, especially for panic disorder and social anxiety.

Best fast-acting, non-addictive option: Hydroxyzine — the closest thing to benzodiazepine speed without the dependence risk.

Best for a known trigger: Beta-blockers — situational and performance anxiety with predictable timing.

Ketamine and the psychedelic trial data (psilocybin, MM120) are worth knowing about but are not first-line, readily accessible anxiety treatments today — treat them as an off-label conversation with a psychiatrist (ketamine) or a future/trial-stage option (psilocybin, MM120), not a starting point.

Never taper a benzodiazepine on your own. Any switch should be planned with your prescriber, especially after regular use of more than a few weeks.